Lucira Health, Inc. (LHDX) Misses Q3 EPS by 277c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
- Nebius shares sink on CoreWeave's bond yield spike and insider sales
- IonQ prices $2 billion equity offering at $40 per share
- Rocket Lab delays Neutron rocket debut to 2027
- Bloom Energy stock falls as inflation data pressures markets
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
Lucira Health Inc. (LHDX) PT Lowered to $0.75 at BofA Securities
November 15, 2022 9:23 AM ESTBofA Securities analyst Derik de Bruin lowered the price target on Lucira Health Inc. (NASDAQ: LHDX) to $0.75 (from $3.00) while maintaining a Underperform rating.
... More


